
    
      A single-center, prospective, randomized, post-market study of patients undergoing
      implantation of a pacemaker, ICD, or S-ICD with or without CanGaroo using the same hydration
      solution. Twenty patients, randomized 1:1 for 10 in the treatment group and 10 in the control
      group, shall be enrolled. Follow-up visits include post-op and 3-months following the
      implantation procedure.
    
  